Search research articles

联系我们

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

隐私政策

政策

Search research articles

联系我们

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

隐私政策

政策

Search research articles

在抗艾滋病疫苗方面取得的进展.

D P Bolognesi¹

¹Department of Surgery, Duke University Medical Center, Durham, NC 27710.

Science (New York, N.Y.)

|December 8, 1989

概括

No abstract available in PubMed .

相关实验视频

在抗艾滋病疫苗方面取得的进展.

相关概念视频

HIV fusion and its inhibition.

Monoclonal antibodies that bind to the core of fusion-active glycoprotein 41.

Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.

Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.

Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus.

Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.

相关实验视频

在抗艾滋病疫苗方面取得的进展.

相关概念视频

相关文章

HIV fusion and its inhibition.

Monoclonal antibodies that bind to the core of fusion-active glycoprotein 41.

Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.

Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.

Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus.

Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.